Literature DB >> 6305198

Characterization of the rat neutrophil formyl peptide chemotaxis receptor.

W A Marasco, J C Fantone, R J Freer, P A Ward.   

Abstract

Numerous synthetic N-formylated peptides, believed to be the analogs of the naturally occurring initiating signal peptides produced by bacteria, are potent chemotactic agents for phagocytic cells in several species. The authors have characterized the receptor with moderately high affinity for the chemotactic peptide f-Met-Leu-[3H]Phe on the rat peritoneal neutrophils. When neutrophils are incubated with f-Met-Leu-[3H]Phe at 24 C, the binding is saturable and reversible. The receptor on the inflammatory rat neutrophils has an equilibrium dissociation constant (KD) of 3.4 x 10(-8) M at 24 C, and there are approximately 65,000 sites per cell. In addition, the potency of several of these chemotactic peptides in inducing lysosomal enzyme secretion and superoxide production correlated well with their ability to compete with f-Met-Leu-[3H]Phe for receptor binding. Structure activity studies further demonstrate that the fine specificity of the formyl peptide receptor has been conserved across species lines.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6305198      PMCID: PMC1916279     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  27 in total

1.  Characterization of functional receptors for somatostatin in rat pituitary cells in culture.

Authors:  A Schonbrunn; H Tashjian
Journal:  J Biol Chem       Date:  1978-09-25       Impact factor: 5.157

Review 2.  A multifunctional receptor on the neutrophil for synthetic chemotactic oligopeptides.

Authors:  E L Becker
Journal:  J Reticuloendothel Soc       Date:  1979-12

3.  N-formylmethionyl peptides as chemoattractants for leucocytes.

Authors:  E Schiffmann; B A Corcoran; S M Wahl
Journal:  Proc Natl Acad Sci U S A       Date:  1975-03       Impact factor: 11.205

4.  Demonstration of a receptor on rabbit neutrophils for chemotactic peptides.

Authors:  S Aswanikumar; B Corcoran; E Schiffmann; A R Day; R J Freer; H J Showell; E L Becker
Journal:  Biochem Biophys Res Commun       Date:  1977-01-24       Impact factor: 3.575

5.  Demonstration of a chemotactic factor receptor on macrophages.

Authors:  R Snyderman; E J Fudman
Journal:  J Immunol       Date:  1980-06       Impact factor: 5.422

6.  Receptor-mediated uptake and degradation of 125I-chemotactic peptide by human neutrophils.

Authors:  J Niedel; S Wilkinson; P Cuatrecasas
Journal:  J Biol Chem       Date:  1979-11-10       Impact factor: 5.157

7.  A subpopulation of cultured human promyelocytic leukemia cells (HL-60) displays the formyl peptide chemotactic receptor.

Authors:  J Niedel; I Kahane; L Lachman; P Cuatrecasas
Journal:  Proc Natl Acad Sci U S A       Date:  1980-02       Impact factor: 11.205

8.  Biochemical quantitation of the chemotactic factor inactivator activity in human serum.

Authors:  J Fantone; R M Senior; D L Kreutzer; M Jones; P A Ward
Journal:  J Lab Clin Med       Date:  1979-01

9.  Specific receptor sites for chemotactic peptides on human polymorphonuclear leukocytes.

Authors:  L T Williams; R Snyderman; M C Pike; R J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

10.  The structure-activity relations of synthetic peptides as chemotactic factors and inducers of lysosomal secretion for neutrophils.

Authors:  H J Showell; R J Freer; S H Zigmond; E Schiffmann; S Aswanikumar; B Corcoran; E L Becker
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

View more
  9 in total

1.  Characterization of a class of nonformylated Enterococcus faecalis-derived neutrophil chemotactic peptides: the sex pheromones.

Authors:  P Sannomiya; R A Craig; D B Clewell; A Suzuki; M Fujino; G O Till; W A Marasco
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

2.  Receptor cleavage reduces the fluid shear response in neutrophils of the spontaneously hypertensive rat.

Authors:  Angela Y Chen; Frank A DeLano; Shakti R Valdez; Jessica N Ha; Hainsworth Y Shin; Geert W Schmid-Schönbein
Journal:  Am J Physiol Cell Physiol       Date:  2010-09-22       Impact factor: 4.249

3.  Inhibition of neutrophil activation by p-bromophenacyl bromide and its effects on phospholipase A2.

Authors:  R E Duque; J C Fantone; C Kramer; W A Marasco; S H Phan
Journal:  Br J Pharmacol       Date:  1986-06       Impact factor: 8.739

4.  In vitro and in vivo effects of piroxicam on rat polymorphonuclear responsiveness after induction of two acute non-specific inflammatory reactions.

Authors:  D P Huy; M Roch-Arveiller; M Lenoir; O Muntaner; A Thuret; J P Giroud
Journal:  Agents Actions       Date:  1986-06

5.  Inhibition of leukocyte chemotaxis by serum factor in diabetes mellitus: selective depression of cell responses mediated by complement-derived chemoattractants.

Authors:  P Sannomiya; M A Pereira; J Garcia-Leme
Journal:  Agents Actions       Date:  1990-06

6.  Modulation of polymorphonuclear leukocyte microbicidal activity and oxidative metabolism by fibrinogen degradation products D and E.

Authors:  J W Kazura; J D Wenger; R A Salata; A Z Budzynski; G H Goldsmith
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

7.  Glutamine depletion potentiates leucocyte-dependent inflammatory events induced by carrageenan or Clostridium difficile toxin A in rats.

Authors:  Silvia B Nascimento; Romualdo B Sousa; Marcos Jullian B Martins; Antoniella Souza Gomes; Marcellus Henrique L P Souza; Richard L Guerrant; Fernando Q Cunha; Ronaldo A Ribeiro; Gerly A C Brito
Journal:  Immunology       Date:  2005-11       Impact factor: 7.397

8.  Rat neutrophil activation and effects of lipoxygenase and cyclooxygenase inhibitors.

Authors:  P A Ward; M C Sulavik; K J Johnson
Journal:  Am J Pathol       Date:  1984-08       Impact factor: 4.307

9.  Mycobacteria attenuate nociceptive responses by formyl peptide receptor triggered opioid peptide release from neutrophils.

Authors:  Heike L Rittner; Dagmar Hackel; Philipp Voigt; Shaaban Mousa; Andrea Stolz; Dominika Labuz; Michael Schäfer; Michael Schaefer; Christoph Stein; Alexander Brack
Journal:  PLoS Pathog       Date:  2009-04-03       Impact factor: 6.823

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.